| Title | Effect of baseline CD4 cell counts on the clinical significance of short-term immunologic response to antiretroviral therapy in individuals with virologic suppression. |
| Publication Type | Journal Article |
| Year of Publication | 2009 |
| Authors | Moore, David M., Ross Harris, Viviane Lima, Bob Hogg, Margaret May, Benita Yip, Amy Justice, Amanda Mocroft, Peter Reiss, Fiona Lampe, Geneviève Chêne, Dominique Costagliola, Luigia Elzi, Michael J. Mugavero, Antonella d'Arminio Monforte, Caroline Sabin, Daniel Podzamczer, Gerd Fätkenheuer, Schlomo Staszewski, John Gill, and Jonathan A. C. Sterne |
| Corporate Authors | Antiretroviral Therapy Cohort Collaboration |
| Journal | Journal of acquired immune deficiency syndromes (1999) |
| Volume | 52 |
| Issue | 3 |
| Pagination | 357-63 |
| Date Published | 2009 Nov 1 |
| ISSN | 1944-7884 |
| Keywords | Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Cohort Studies, Drug Administration Schedule, Female, HIV Infections, Humans, Male, Middle Aged |
| Abstract | Achieving virologic suppression is a clear therapeutic goal for patients receiving combination antiretroviral therapy (cART). However, the effects of immunologic responses, whether measured as CD4 count changes from baseline or CD4 counts at follow-up, in patients with virologic suppression, have not been clearly established. |
| DOI | 10.1097/QAI.0b013e3181b62933 |
| Alternate Journal | J. Acquir. Immune Defic. Syndr. |
